Regret is rare among transgender youth who began hormone therapy, according to largest study of its kind
A cohort study published in JAMA Pediatrics, the largest of its kind, found that 96.8% of transgender youth who began hormone therapy said it was the right decision, with an average regret score of 4.3 out of 100. Even among those who later stopped taking hormones, more than four in five still said starting had been the right choice.
By Dr Helen WebberleyResponding to PsyPost16 November 20265 min read
Photo by Kateryna Hliznitsova on Unsplash
A cohort study published in JAMA Pediatrics, the largest of its kind, found that 96.8% of transgender youth who began hormone therapy said it was the right decision, with an average regret score of just 4.3 out of 100. Even among those who later stopped taking hormones, more than four in five still said starting had been the right choice.
What the study found
This research, led by Laura Kuper at the University of Texas Southwestern Medical Center, followed 376 young people who had started oestrogen or testosterone at a multidisciplinary US gender clinic. They ranged in age from 14 to 28 at the time of the survey, had started hormones at an average age of 16, and had been followed for an average of nearly five years, with some followed for close to eleven. The team used the Decision Regret Scale, a validated five-item tool scored from zero to 100, and they explicitly invited people who had stopped taking hormones or left the clinic to participate. That matters, because studies that only capture current patients can miss the people most likely to have mixed feelings.
The results were clear. The average regret score was 4.3. The median was zero. Most young people, when asked directly, reported no regret at all. As the authors note, the average regret score across other medical decisions measured by the same scale is 16.5. The young people in this study came in well under a quarter of that.
Ten participants, 2.7%, agreed or strongly agreed that they regretted the choice. Seven, 1.9%, said it had done them a lot of harm. Those experiences are real and they deserve to be taken seriously, and the study does take them seriously. Nine of those participants wrote open-ended explanations, describing feeling unprepared due to their age or maturity, insufficient parental or therapeutic support, physical changes they no longer wanted, or concerns about fertility. That is not a reason to withhold care from the 96.8%. It is a reason to think hard about how care is delivered, what support looks like, and how information is shared.
Why stopping hormones is not the same as regretting them
Seventeen percent of participants were no longer taking hormones when surveyed. Their regret scores were, on average, about 16 points higher than those still on hormones. But even within that group, more than four in five said starting treatment had been the right decision.
This distinction is not new, but it keeps getting flattened in public debate. Stopping is not regret. People stop hormones for all kinds of reasons: cost, access, changing circumstances, shifting priorities, relationships, health, social pressure. A 2021 survey of transgender adults found that the most common reasons people had paused or reversed transition were external, things like family rejection and social stigma, not a changed view of their own identity. This study adds to that picture. The assumption that any discontinuation signals regret has never been well-supported by evidence, and this research pushes back on it again.
Why this study matters now
The fear of regret has been doing a lot of political work lately. It has been used to justify restricting access to gender-affirming care for young people across numerous US states, and to frame the entire question of adolescent medical transition as reckless or premature. The Cass Review in the UK leaned heavily on uncertainty and caution, contributing to a ban on private prescriptions for puberty blockers that has caused real harm to real young people.
What the evidence has consistently shown, and what this study reinforces with greater scale and longer follow-up than anything before it, is that the young people who access this care are overwhelmingly glad they did. The regret narrative has never matched the data. It has matched the anxiety of people who are not trans, imagining what they would feel, rather than the experience of people who are.
This study is not a random sample of all trans young people; it draws on participants from one US clinic who agreed to longitudinal research. The authors are transparent about that. Response rates, who agreed to participate, and who did not are all discussed openly. The researchers found that people assigned male at birth and those with documented physical gender distress before puberty were slightly less likely to complete the follow-up, which is worth noting. But the scale here, nearly 400 participants followed for up to eleven years, is genuinely significant, and the direction of the findings is consistent with the broader body of research.
Regret was never the right question
Even if regret were more common than this study shows, it still would not settle the question of whether care should be provided. We do not organise access to any other area of medicine around the worst-case feelings of a minority of patients after the fact. We weigh benefits against risks, we take informed consent seriously, we improve the quality of care when things go wrong. Gender-affirming care deserves exactly the same standard, and this study shows it clears that bar.
What the data shows is not that everything is perfect or that every young person's experience is straightforward. It shows that the overwhelming majority of trans young people who access hormone therapy are glad they did, including the majority of those who later stopped taking hormones. The young people who are not glad deserve better support and better preparation. The young people who are glad deserve access that is not held hostage to the fears of people who have never had to live in a body that doesn't match who they are.
This study will not end the political debate. Studies rarely do. But it adds a substantial, carefully conducted piece of evidence to a picture that has been consistent for years: when trans young people get the care they need, most of them look back and say it was the right decision. That is not a footnote. That is the finding.
If there is a news story you would like me to cover then just let Sammy know.
Dr Helen Webberley is a Gender Expert and Medical Educator, and the founder of GenderGP. She writes about gender diversity, trans healthcare, and the lives of trans people and their families.
In response toRegret is rare among transgender youth who began hormone therapy, according to largest study of its kindPsyPost
Talk it through with Sammy
Sammy has read this with you, and can help you work out what it means for you.
Comments